FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010641649> ?p ?o ?g. }

• W2010641649 endingPage "1594" @default.
• W2010641649 startingPage "1585" @default.
• W2010641649 abstract "Background: The spread of resistant Salmonella strains continues to increase worldwide. It is necessary to establish epidemiologic information to determine an appropriate empiric antibiotic regimen (when indicated) in infants and children with suspected Salmonella infections for whom the results of susceptibility tests are not yet available. Objectives: The aim of the present study was to investigate resistance rates and their modifications among Salmonella enterica strains isolated from Italian children hospitalized for acute diarrhea over 5 years. In addition, when antibiotic treatment was indicated, we assessed the in vivo success of parenteral ceftriaxone therapy. Methods: This study included children admitted consecutively for acute diarrhea to the Division of Pediatrics and Infectious Diseases, Department of Pediatrics, University of Florence, Italy, from January 1, 1997, to December 31, 2001. S enterica strains were isolated from stool cultures, biochemically identified, and serotyped. These isolates were tested by disk-diffusion assay, using the Kirby-Bauer method, for susceptibilities to ampicillin, ceftriaxone, ciprofloxacin, chloramphenicol, neomycin, tetracycline, and trimethoprim/sulfamethoxazole. The limits used for definition of resistance were those established by the guidelines of the National Committee for Clinical Laboratory Standards. Results: A total of 2003 children (1051 boys, 952 girls; median age, 10.3 years; age range, 1 month–16.8 years) with acute diarrhea were admitted to the study. S enterica strains were isolated using stool cultures from 218 (10.9%) children (108 boys, 110 girls; median age, 3.3 years; age range, 2 months–15.8 years). A total of 148 (67.9%) isolates were resistant to at least 1 antibiotic and 57 (26.1%) were multiresistant. The highest rates of resistance were those to tetracycline ( [60.6%]), ampicillin ( [46.8%]), and chloramphenicol ( [21.6%]). The lowest rate of resistance was to ceftriaxone ( [1.8%]). Overall, the rate of resistance to ciprofloxacin ( [8.7%]) was significantly higher than that for ceftriaxone (P = 0.003). Salmonella typhimurium ( [54.6%]) and Salmonella enteritidis ( [28.4%]) were the most frequently identified serotypes. Ceftriaxone was effective in vivo in all 56 children who required antibiotic therapy. Conclusions: There was a high prevalence of resistant S enterica strains. Ceftriaxone was used effectively in the treatment of S enterica infection in the population studied." @default.
• W2010641649 created "2016-06-24" @default.
• W2010641649 creator A5019249687 @default.
• W2010641649 creator A5023419691 @default.
• W2010641649 creator A5032403243 @default.
• W2010641649 creator A5046801644 @default.
• W2010641649 creator A5086923044 @default.
• W2010641649 date "2002-10-01" @default.
• W2010641649 modified "2023-09-26" @default.
• W2010641649 title "Results of a 5-year prospective surveillance study of antibiotic resistance among Salmonella enterica isolates and ceftriaxone therapy among children hospitalized for acute diarrhea" @default.
• W2010641649 cites W1978859550 @default.
• W2010641649 cites W1982703286 @default.
• W2010641649 cites W1988649503 @default.
• W2010641649 cites W2016085294 @default.
• W2010641649 cites W2022418207 @default.
• W2010641649 cites W2035150578 @default.
• W2010641649 cites W2041184655 @default.
• W2010641649 cites W2051301545 @default.
• W2010641649 cites W2071981537 @default.
• W2010641649 cites W2092596426 @default.
• W2010641649 cites W2110609722 @default.
• W2010641649 cites W2116789340 @default.
• W2010641649 cites W2122914379 @default.
• W2010641649 cites W2125428084 @default.
• W2010641649 cites W2128676609 @default.
• W2010641649 cites W2154323677 @default.
• W2010641649 cites W2167174099 @default.
• W2010641649 cites W2409397590 @default.
• W2010641649 cites W4251254864 @default.
• W2010641649 doi "https://doi.org/10.1016/s0149-2918(02)80062-5" @default.
• W2010641649 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12462288" @default.
• W2010641649 hasPublicationYear "2002" @default.
• W2010641649 type Work @default.
• W2010641649 sameAs 2010641649 @default.
• W2010641649 citedByCount "40" @default.
• W2010641649 countsByYear W20106416492013 @default.
• W2010641649 countsByYear W20106416492014 @default.
• W2010641649 countsByYear W20106416492015 @default.
• W2010641649 countsByYear W20106416492016 @default.
• W2010641649 countsByYear W20106416492017 @default.
• W2010641649 countsByYear W20106416492018 @default.
• W2010641649 countsByYear W20106416492019 @default.
• W2010641649 countsByYear W20106416492020 @default.
• W2010641649 countsByYear W20106416492021 @default.
• W2010641649 countsByYear W20106416492022 @default.
• W2010641649 crossrefType "journal-article" @default.
• W2010641649 hasAuthorship W2010641649A5019249687 @default.
• W2010641649 hasAuthorship W2010641649A5023419691 @default.
• W2010641649 hasAuthorship W2010641649A5032403243 @default.
• W2010641649 hasAuthorship W2010641649A5046801644 @default.
• W2010641649 hasAuthorship W2010641649A5086923044 @default.
• W2010641649 hasConcept C126322002 @default.
• W2010641649 hasConcept C187212893 @default.
• W2010641649 hasConcept C2776021129 @default.
• W2010641649 hasConcept C2776520383 @default.
• W2010641649 hasConcept C2778512257 @default.
• W2010641649 hasConcept C2779607309 @default.
• W2010641649 hasConcept C2779802037 @default.
• W2010641649 hasConcept C2780728791 @default.
• W2010641649 hasConcept C2781065037 @default.
• W2010641649 hasConcept C501593827 @default.
• W2010641649 hasConcept C523546767 @default.
• W2010641649 hasConcept C54355233 @default.
• W2010641649 hasConcept C71924100 @default.
• W2010641649 hasConcept C86803240 @default.
• W2010641649 hasConcept C89423630 @default.
• W2010641649 hasConcept C94665300 @default.
• W2010641649 hasConceptScore W2010641649C126322002 @default.
• W2010641649 hasConceptScore W2010641649C187212893 @default.
• W2010641649 hasConceptScore W2010641649C2776021129 @default.
• W2010641649 hasConceptScore W2010641649C2776520383 @default.
• W2010641649 hasConceptScore W2010641649C2778512257 @default.
• W2010641649 hasConceptScore W2010641649C2779607309 @default.
• W2010641649 hasConceptScore W2010641649C2779802037 @default.
• W2010641649 hasConceptScore W2010641649C2780728791 @default.
• W2010641649 hasConceptScore W2010641649C2781065037 @default.
• W2010641649 hasConceptScore W2010641649C501593827 @default.
• W2010641649 hasConceptScore W2010641649C523546767 @default.
• W2010641649 hasConceptScore W2010641649C54355233 @default.
• W2010641649 hasConceptScore W2010641649C71924100 @default.
• W2010641649 hasConceptScore W2010641649C86803240 @default.
• W2010641649 hasConceptScore W2010641649C89423630 @default.
• W2010641649 hasConceptScore W2010641649C94665300 @default.
• W2010641649 hasIssue "10" @default.
• W2010641649 hasLocation W20106416491 @default.
• W2010641649 hasLocation W20106416492 @default.
• W2010641649 hasOpenAccess W2010641649 @default.
• W2010641649 hasPrimaryLocation W20106416491 @default.
• W2010641649 hasRelatedWork W2019229414 @default.
• W2010641649 hasRelatedWork W2061157550 @default.
• W2010641649 hasRelatedWork W2132194827 @default.
• W2010641649 hasRelatedWork W2370364184 @default.
• W2010641649 hasRelatedWork W2461645720 @default.
• W2010641649 hasRelatedWork W3037751898 @default.
• W2010641649 hasRelatedWork W3184943381 @default.
• W2010641649 hasRelatedWork W347892539 @default.
• W2010641649 hasRelatedWork W4224045994 @default.
• W2010641649 hasRelatedWork W4280627593 @default.

• next